about
NetPath: a public resource of curated signal transduction pathwaysFocus on adoptive T cell transfer trials in melanomaCD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.Adoptive immunotherapy for cancer: building on successCancer immunotherapy: moving beyond current vaccinesT cell homeostatic proliferation elicits effective antitumor autoimmunityImmunomic analysis of human sarcomaIL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsGene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenNormal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cellsRecognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytesHost microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesisDiversity and recognition efficiency of T cell responses to cancerDetection and characterization of cellular immune responses using peptide-MHC microarraysA modified human ELISPOT assay to detect specific responses to primary tumor cell targetsUpdate on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition.Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cellsPhenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcomaMarked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.T cell avidity and tumor recognition: implications and therapeutic strategies.Nerve growth factor: role in growth, differentiation and controlling cancer cell developmentRecent advances of biomaterials in biotherapyNovel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialImmunotherapy in gastric cancerStructural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptorPretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-AnalysisPrognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysisHarnessing the Microbiome to Enhance Cancer ImmunotherapyNovel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA librariesTumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genesNovel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma libraryRole of cancer microenvironment in metastasis: focus on colon cancerMetastasis: a question of life or deathSurvivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignanciesIn silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancerFormation and role of exosomes in cancer.Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.Temporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.
P2860
Q21184104-6ECC33E3-2CE2-4592-9346-71F2F4038E10Q21328679-45142B3E-BC9F-405D-BC65-63BFA836CD32Q24540429-2A26DA50-8E8D-460D-8A7D-D7D690268B07Q24546258-2BF1CA99-8842-4202-AD97-6F51E01F0EFEQ24548229-E99D2999-C51D-4802-9963-8C24FBC99921Q24553060-FF4C0DC6-E551-428D-95AF-F6369E15EDC0Q24554211-9A4DCE83-6F03-4F4E-AB32-34B278050499Q24621753-76E43A4E-9D10-4651-96C8-A80586F421E9Q24623215-7B707B05-4658-4BAC-8A64-3F6755C0B443Q24648492-F76AC3A9-F4BD-4C70-906C-9420E068FC86Q24658494-268EBACC-F6DB-4D06-89AF-3453D2C5ED1BQ24672952-CEACB5D7-F80B-4C2F-AAE9-56DA666CB94DQ24795592-307C92ED-2311-4962-A0BF-EDB2E571C1E8Q24796652-3DE591DA-B026-43E8-ACAE-384CBB7ACBDAQ24800142-550034D1-9E2F-4ADF-8C92-F61D6FF0E2BEQ24800412-F80976CA-B447-43EA-932A-169E843EF637Q24801995-229DBC16-8AF2-49BD-B4A8-C8EC90259E70Q24802970-6D6FA75D-AEE0-48A5-8FD7-2CCA411478ABQ24814867-B5C76D77-AE79-466C-BD6B-952AEF68532EQ24815128-DF7672B4-BC9A-4832-8057-176366A103C0Q24815775-D295EAE7-BBC8-44DB-AA4E-D2CBC3EA2796Q26738684-56CFD6F6-4EC2-40FF-9F77-AD17EB4880D9Q26752054-00CE2D13-938E-42CC-908B-AEB6E33625C7Q26769884-ABC5052E-B4FF-463C-9223-235C80E89CADQ27010472-074ED0AE-FB73-4178-B722-718B2267CBB8Q27643966-39B72475-AB8C-4CB7-9766-3E22B85E5A97Q28070039-B0D97573-D07C-43D1-9CB0-C7EC92528B6EQ28083684-48C04312-1777-4D32-A1E3-721E65EC0A98Q28088598-CDE5AA23-D0D5-4558-8E30-1936E137B5D9Q28178383-14A834F8-FA84-413F-860D-2177EAECA433Q28219945-20025B7F-13CF-4102-8D86-7DD15E10F594Q28220472-EBE0C76C-6EAD-4014-9B5B-DF31F052B730Q28239062-2314CA18-2FAD-4F21-BD8B-0031B13A0CFBQ28242176-91C37E04-D233-47D5-9489-F0C0B81A4356Q28251858-17A488E4-B4B2-4DC7-A372-B6CB811D835EQ28303131-19712B5D-83D1-4153-BE07-3F5B244F2FD4Q30303067-FD0B2CEA-1696-4AE4-8BD4-564F9471612BQ30641952-252D7467-BE55-45AE-B08D-6FDB9FC7C75AQ31033273-8073473F-5DC8-4354-8D5E-E97A7EA39331Q33222048-BD4390D3-2670-4B42-AFFC-CA4C1B757A46
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Progress in human tumour immunology and immunotherapy.
@ast
Progress in human tumour immunology and immunotherapy.
@en
Progress in human tumour immunology and immunotherapy.
@nl
type
label
Progress in human tumour immunology and immunotherapy.
@ast
Progress in human tumour immunology and immunotherapy.
@en
Progress in human tumour immunology and immunotherapy.
@nl
prefLabel
Progress in human tumour immunology and immunotherapy.
@ast
Progress in human tumour immunology and immunotherapy.
@en
Progress in human tumour immunology and immunotherapy.
@nl
P356
P1433
P1476
Progress in human tumour immunology and immunotherapy.
@en
P2093
Rosenberg SA
P2888
P304
P356
10.1038/35077246
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1024176319